Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Claims Emerge To Join “Natural” As Class Action Fodder

16 Dec 2013

• By Elizabeth Crawford

Related Content

FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement

18 May 2009

Trade Groups Defend Qualified Health Claims Following Critical GAO Report

20 Oct 2008

Regulatory News In Brief

22 Apr 2013

J&J Settles Class Action For “Misleading” <em>Neutrogena </em>Naturals Claims

28 Jan 2013

In Absence Of Standards For Natural, NAD Focuses On Context

22 Oct 2012

Class Action Claims Often Follow Regulatory Action, Industry Litigation

30 Jan 2012

Related Companies

Johnson & Johnson

Additional Topics

United States Advertising, Marketing & Sales Regulation Compliance OTC Drugs Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.